default author photo

Wim Terpstra

University of Amsterdam

Spui 21

Amsterdam, 1018 WB

Netherlands

SCHOLARLY PAPERS

1

DOWNLOADS

158

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

R-CODOX-M/R-IVA Versus DA-EPOCH-R in Patients with Newly Diagnosed Burkitt Lymphoma. Final Results of A Multicenter Randomized HOVON/SAKK Trial

Number of pages: 29 Posted: 07 Aug 2023
VU University Amsterdam - Department of Haematology, University of Basel - University Hospital Basel, HOVON Foundation, University of Bern - Department of Medical Oncology, Utrecht University - University Medical Center (Utrecht), Isala Hospital, Radboud University Nijmegen - Radboud University Medical Center, University Hospital Zurich, University of Groningen - University Medical Center Groningen, ZNA Stuivenberg, ZNA Stuivenberg, Maastricht University, University of Amsterdam, Maxima Medical Centre, AZ Delta General Hospital, UCL Saint-Luc, Luzerner Kantonsspital, Leiden University, Medical Center (LUMC), Department of Hematology, Haga Hospital, Kantonsspital Baden, Erasmus University Rotterdam (EUR) - Department of Hematology, affiliation not provided to SSRN, HOVON Foundation, HOVON Foundation, Netherlands Cancer Institute, Erasmus University Rotterdam (EUR), University of Basel - University Hospital Basel, Radboud University, University of Amsterdam, University of Groningen - University Medical Center Groningen and Erasmus University Rotterdam (EUR)
Downloads 158 (472,207)

Abstract:

Loading...

Burkitt Lymphoma LymphomaR-CODOX-M/R-IVACDA-EPOCH-RSurvivalToxicity